Literature DB >> 2241906

Inhibitors of phospholipase A2 block the stimulation of protein synthesis by insulin in L6 myoblasts.

B G Southorn1, R M Palmer.   

Abstract

Insulin at a concentration close to the physiological range (100 mu-units/ml) stimulated protein synthesis in L6 myoblasts by 17%. Pre-treatment with the phospholipase A2 inhibitors mepacrine or dexamethasone prevented this stimulation and decreased the release of prostaglandin F2 alpha, implicating the action of phospholipase A2 and the subsequent metabolism of arachidonic acid to prostaglandins in the stimulation of protein synthesis by physiological doses of insulin. Higher concentrations of insulin (500-1000 mu-units/ml) stimulated protein synthesis in the presence of mepacrine or dexamethasone, suggesting that an alternative pathway may become important in insulin action when phospholipase A2 is inhibited.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2241906      PMCID: PMC1131793          DOI: 10.1042/bj2700737

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  14 in total

1.  The role of insulin, corticosterone and other factors in the acute recovery of muscle protein synthesis on refeeding food-deprived rats.

Authors:  D J Millward; B Odedra; P C Bates
Journal:  Biochem J       Date:  1983-12-15       Impact factor: 3.857

Review 2.  Inhibition of phospholipase.

Authors:  G J Blackwell; R J Flower
Journal:  Br Med Bull       Date:  1983-07       Impact factor: 4.291

3.  Changes in prostaglandin release associated with inhibition of muscle protein synthesis by dexamethasone.

Authors:  P J Reeds; R M Palmer
Journal:  Biochem J       Date:  1984-05-01       Impact factor: 3.857

4.  Indomethacin inhibits the insulin-induced increases in RNA and protein synthesis in L6 skeletal muscle myoblasts.

Authors:  R M Palmer; P A Bain
Journal:  Prostaglandins       Date:  1989-02

5.  Insulin stimulation of protein synthesis in cultured skeletal and cardiac muscle cells.

Authors:  J Airhart; J A Arnold; W S Stirewalt; R B Low
Journal:  Am J Physiol       Date:  1982-07

6.  Prolactin actions on casein and lipid biosynthesis in mouse and rabbit mammary gland explants are abolished by p-bromphenacyl bromide and quinacrine, phospholipase A2 inhibitors.

Authors:  J A Rillema; R N Etindi; C M Cameron
Journal:  Horm Metab Res       Date:  1986-10       Impact factor: 2.936

7.  The possible involvement of prostaglandin F2 alpha in the stimulation of muscle protein synthesis by insulin.

Authors:  P J Reeds; R M Palmer
Journal:  Biochem Biophys Res Commun       Date:  1983-11-15       Impact factor: 3.575

8.  Regulation of protein accumulation in cultured cells.

Authors:  F J Ballard
Journal:  Biochem J       Date:  1982-11-15       Impact factor: 3.857

9.  Prostaglandin production in myotube cultures. Influence on protein turnover.

Authors:  M A McElligott; L Y Chaung; V Baracos; E A Gulve
Journal:  Biochem J       Date:  1988-08-01       Impact factor: 3.857

10.  A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids.

Authors:  F Hirata; E Schiffmann; K Venkatasubramanian; D Salomon; J Axelrod
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

View more
  7 in total

Review 1.  The prevention and treatment of exercise-induced muscle damage.

Authors:  Glyn Howatson; Ken A van Someren
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

2.  Biosynthesis of the endogenous cyclic adenosine monophosphate (AMP) antagonist, prostaglandylinositol cyclic phosphate (cyclic PIP), from prostaglandin E and activated inositol polyphosphate in rat liver plasma membranes.

Authors:  H K Wasner; M Lessmann; M Conrad; H Amini; E Psarakis; A Mir-Mohammad-Sadegh
Journal:  Acta Diabetol       Date:  1996-07       Impact factor: 4.280

Review 3.  The skeletal muscle arachidonic acid cascade in health and inflammatory disease.

Authors:  Marina Korotkova; Ingrid E Lundberg
Journal:  Nat Rev Rheumatol       Date:  2014-01-28       Impact factor: 20.543

4.  Effect of a tumour-produced lipid-mobilizing factor on protein synthesis and degradation.

Authors:  B S Islam-Ali; M J Tisdale
Journal:  Br J Cancer       Date:  2001-06-15       Impact factor: 7.640

5.  Induction of mast cell accumulation, histamine release and skin edema by N49 phospholipase A2.

Authors:  Ji-Fu Wei; Xiao-Long Wei; Ya-Zhen Mo; Shao-Heng He
Journal:  BMC Immunol       Date:  2009-04-28       Impact factor: 3.615

6.  Induction of mast-cell accumulation by promutoxin, an Arg-49 phospholipase A2.

Authors:  Ji-Fu Wei; Xiao-Long Wei; Ya-Zhen Mo; Haiwei Yang; Shaoheng He
Journal:  Biomed Res Int       Date:  2012-12-20       Impact factor: 3.411

7.  Uncoupling of growth inhibition and differentiation in dexamethasone-treated human rhabdomyosarcoma cells.

Authors:  C De Giovanni; P L Lollini; R Dolcetti; L Landuzzi; G Nicoletti; E D'Andrea; K Scotland; P Nanni
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.